pharmaceutical investing Acerus Updates on Temporary Unavailability of NATESTO in Canada and South Korea
pharmaceutical investing VIDEO - Acerus Pharma CEO: Keeping Focus on Drug Delivery Tech, Not Cannabis
Acerus Receives Notice of Deficiency – Withdrawal Letter from Health Canada Regarding Gynoflor Application
pharmaceutical investing Acerus Announces Results of Phase 1 Clinical Trial with a Proprietary Intranasal Formulation of a Tetrahydrocannabinol-Rich Cannabis Oil
pharmaceutical investing Acerus Provides Update on Continuing Commercial and R&D Achievements for NATESTO®
pharmaceutical investing Acerus Announces Expansion of NATESTO® Agreement with medac and the Submission of NATESTO® Dossier in Europe
FPX Nickel Completes Production Run of Battery-Grade Nickel Sulphate to Support Discussions with Prospective EV Battery Supply Chain Partners
Blackrock Silver Drills Multiple +1 kg/t AgEq Intercepts and Establishes Grade Continuity over 350 Metres in Final M&I Conversion Assays at Tonopah West
Ellis Martin Report: Blue Lagoon Resources Inc.'s (BLAGF) Rana Vig - Investors are Seeking Producing Gold Companies
